| Page No 1 2 3 4 5 6 7 8 9 |
| Phrase | Consultant | Town | Special Interests |
| Microbiology | *Consultant(s)* | *Towns* | Infection/antimicrobial therapy |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, antimicrobial therapy, medical education |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases, virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Microbiology, virology |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, bacteriology |
| Microbiology | *Consultant(s)* | *Towns* | Infection control and management |
| Microbiology | *Consultant(s)* | *Towns* | Antimicrobial stewardship |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, C difficile |
| Microbiology | *Consultant(s)* | *Towns* | Hospital infection control and prevention |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Neonatal sepsis, group B streptococci, antimicrobial resistance |
| Microbiology | *Consultant(s)* | *Towns* | Management of infection in the diabetic foot |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Medical education, laboratory medicine |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, cardiac infections, renal infections |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Synergy testing, infection control, environmental screening |
| Microbiology | *Consultant(s)* | *Towns* | Virology, infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control and prevention |
| Microbiology | *Consultant(s)* | *Towns* | Infection diseases, Q fever, hepatitis C |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, management of clostridium difficile, MRSA, community acquired pneumonia, antibiotic therapy in adult respiratory disease |
| Microbiology | *Consultant(s)* | *Towns* | Bone and joint infection and infection in the immunocompromised, OPAT - outpatient parenteral antimicrobial therapy |
| Microbiology | *Consultant(s)* | *Towns* | Mycology |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control and prevention |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | TB - tuberculosis |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, antifungals in critical care |
| Microbiology | *Consultant(s)* | *Towns* | Virology, infection control, viral hepatitis |
| Microbiology | *Consultant(s)* | *Towns* | Microbiology, COVID-19 |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control, sepsis |
| Microbiology | *Consultant(s)* | *Towns* | Acute infection control |
| Microbiology | *Consultant(s)* | *Towns* | Antibiotic resistance |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control, bone and joint infection |
| Microbiology | *Consultant(s)* | *Towns* | Infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention, bone and joint infection |
| Microbiology | *Consultant(s)* | *Towns* | Virology, infectious diseases |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Infectious disease epidemiology |
| Microbiology | *Consultant(s)* | *Towns* | Antimicrobial prescribing for clostridium difficile, antimicrobial prophylaxis against infective endocarditis |
| Microbiology | *Consultant(s)* | *Towns* | Infection prevention and control |
| Microbiology | *Consultant(s)* | *Towns* | Infection control |
| Page No 1 2 3 4 5 6 7 8 9 |
